Navigation Links
Full Results of AIDS Vaccine Trial Confirm Modest Benefit
Date:10/20/2009

e U.S. National Institute of Allergy and Infectious Diseases, one of the trial's sponsors, told The New York Times last month.

"For more than 20 years now, vaccine trials have essentially been failures," he said. "Now it's like we were groping down an unlit path, and a door has been opened. We can start asking some very important questions."

The World Health Organization and the U.N. agency UNAIDS said in September that the results "instilled new hope" in the field of HIV vaccine research.

The vaccine is a combination of two vaccines that had previously been unsuccessful in clinical trials. When the Thai clinical trial began in 2006, many scientists thought it would also fail.

The study, which used strains of HIV common in Thailand, tested the two-vaccine combination in what's called a "prime-boost" approach. The first vaccine primes the immune system to attack HIV and the second one strengthens the response.

The two vaccines are called ALVAC and AIDSVAX. ALVAC contains canarypox -- a bird virus that has been genetically altered so it can't cause disease in humans -- to transport synthetic versions of three HIV genes into the body. AIDSVAX contains a genetically engineered version of a protein on HIV's surface. Because the vaccines aren't made from a whole virus -- either dead or alive -- they can't cause AIDS, according to the Associated Press.

The study was done in Thailand because U.S. Army scientists did key research in that country when the AIDS epidemic emerged there, isolating virus strains and providing genetic information on them to vaccine makers. The Thai government also strongly supported the idea of doing the study, the AP reported.

For the trial, half of the 16,402 volunteers were given six doses of the two vaccines in 2006 and half were given placebos. They then got regular HIV tests for three years. Fifty-one of those who got the vaccines became infected comp
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conference Provide Insight for Future Research
2. Cardiome Pharma Corp. Announces Final Results of Tender Offer
3. Omnicell to Release Third Quarter 2009 Earnings Results on October 22
4. Smart Balance to Host Webcast/Conference Call on 2009 Third-Quarter Results
5. Herley Reports Fourth Quarter and Year-End Results
6. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2010 Results
7. ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009
8. BioMed Realty Trust to Report 2009 Third Quarter Results
9. OnBase Equals Bottom Line Results for the 2009 RealSolutions Winners
10. Webcast Alert: Usinas Siderurgicas de Minas Gerais S.A. - USIMINAS Announces Third Quarter 2009 Results Webcast
11. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2009 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (HealthDay News) -- Children and teens who lose a parent ... adulthood, a new study suggests. People who were children ... greater risk of death during the study period than those ... to the report. Although the study found an association ... premature death, it wasn,t designed to prove cause-and-effect. Also, ...
(Date:7/23/2014)... 2014 SafeUseNow? , a ... developed by Principled Strategies , today announced ... California . Utilizing SafeUseNow’s patent-pending risk model, Partnership ... misusing and abusing controlled substance drugs, particularly prescription ... its members. , The agreement with Partnership HealthPlan ...
(Date:7/23/2014)... Texas (PRWEB) July 23, 2014 ... 2020?, provides key market data on the North ... value, in millions of US dollars, and volume ... dollars), within market categories Cardiac Valve Repairs and ... shares and distribution shares data for each of ...
(Date:7/23/2014)... By using brightly hued dyes, George Mason University ... proteins touch each other, possibly leading to new ... lung disease. , George Mason researchers unraveled the ... touch each other. "One protein interlocks with another ... and this sends a signal down the line ...
(Date:7/23/2014)... 2014 Splashtop , a ... that it has joined the RSA Ready Technology ... Enterprise and RSA SecurID® multi-factor authentication solution from ... , Splashtop also announced that leading Japanese ... Splashtop Enterprise, the industry’s only on-premise remote access ...
Breaking Medicine News(10 mins):Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 3Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 5Health News:Researchers unlock the protein puzzle 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3
... , COLUMBUS, Ohio, Dec. 14 Skilled nursing ... services in order to deal with a 92 percent increase in ... $12.01 per bed per day, scheduled for December 15. The ... to the state each month, or $210,240 per year, for a ...
... , DENVER, Dec. 14 On December 9, 2009, ... government,s position that private insurance companies are "plans" and therefore subject ... have held that contracts issued by insurance companies may be subject ... Frost is the first case an insurance company itself has ...
... study finds, , MONDAY, Dec. 14 (HealthDay News) -- Here,s good ... or two of java: Coffee and tea consumption may decrease the ... of an Australian study that also found the more coffee you ... was associated with a 7 percent reduction in the risk of ...
... age to physical, mental functioning , , MONDAY, Dec. 14 ... tend to live longer than those who look older than ... from research that involved 1,826 Danish twins, aged 70 and ... had their faces photographed. Three groups of volunteers looked at ...
... , AAHC Urges Congress to Ensure ... Congressional leaders must ensure that health reform includes a ... of an integrated, coordinated national health workforce policy, according to ... of Academic Health Centers (AAHC). "With each step in ...
... Dec. 14 Anthem Blue Cross announced today that the ... the Tri-County Commercial contract renewal to provide Medi-Cal benefits to ... is the second largest expansion and the third largest renewal ... contract allows Anthem Blue Cross, State Sponsored Business to continue ...
Cached Medicine News:Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3Health News:Insurance Now Subject to Federal Jurisdiction 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:Looking Younger Than Your Age May Mean Longer Life 2Health News:Health Reform Needs Enforceable National Workforce Strategy 2Health News:Anthem Blue Cross Wins Third Largest Medicaid Managed Care Contract Renewal in the Country 2
(Date:7/23/2014)... -- Use of Risk Evaluation and Mitigation Strategies (REMS) ... entry results in $5.4 billion in lost savings annually, ... by economic consulting firm Matrix Global Advisors ... Required by the Food and Drug Administration (FDA) ... intended to improve drug safety by ensuring that the ...
(Date:7/23/2014)... 2014 /PRNewswire-iReach/ -- Top Staten Island Pediatrician Dr. ... on article, which discusses tips for parents about pool safety ... According to US News article, "Drowning ... American children aged 1 to 4, and can occur in ... expert in the article says that watching a child in ...
(Date:7/23/2014)... , July 23, 2014 PositiveID Corp. (OTCQB: ... , is an emerging player in the ... for bio-threat detection and rapid medical testing. The ... (Microfluidic Bio-agent Autonomous Networked Detector), was developed under ... ("DHS") Science & Technology directorate, and $30 million ...
Breaking Medicine Technology:New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2
... Oramed,Pharmaceuticals, Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), ... that its abstract, entitled "Open,Label Study to ... of Five Oral Insulin Formulations in Healthy,Subjects," ... upcoming 44th Annual,Meeting of the European Association ...
... Industry Leader with Strong Clinical Research Relationships and ... Organizations to Lead Commercialization, SANTA CLARA, Calif., ... a cardiac diagnostic and services company, today,announced that ... president. Mr.,Renz will oversee the Company,s commercialization effort, ...
Cached Medicine Technology:Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Vincent W. Renz Joins NewCardio as President 2Vincent W. Renz Joins NewCardio as President 3Vincent W. Renz Joins NewCardio as President 4
For the direct quantitative determination of low density lipoprotein cholesterol (LDL-C) in human serum or plasma. For in vitro diagnostic use only....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
Intended for the quantitative determination of uric acid in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 20 mg/dL (1190 mol/L). Single vial, dry powder reagent....
... A fully automated, random ... over 50 assays available ... tumor marker, therapeutic drug, ... testing can be performed ...
Medicine Products: